Real-time enrollment status for this aml clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT06788756 |
| Recruiting Status | Recruiting |
| Condition | AML |
| Phase | Clinical Trial |
| Target Enrollment | 312 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Moleculin Biotech, Inc. |
| Last Updated on CT.gov | December 16, 2025 (Dec 16, 2025) |
As of March 2, 2026: Clinical trial NCT06788756 is currently recruiting participants. This clinical trial study for aml is actively seeking new participants at 2 locations across the United States. The study is sponsored by Moleculin Biotech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06788756 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06788756 was last updated Dec 16, 2025 (December 16, 2025). HelloStudys verifies this status automatically.